Nova Patents
PT3074396T

1-(5-tert-butyl-2-aryl-pyrazol-3-yl)-3-[2-fluoro-4-[(3-oxo-4h-pyrido[2, 3-b]pyrazin-8-yl)oxy]phenyl]urea derivatives as raf inhibitors for the treatment of cancer

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

36 members in 19 offices

This recordMember, by publication datePriority claim9 more offices are in the list below

Priority claims3

Priority claims
DocumentOfficeKindDate
201320729United KingdomA
201320729United KingdomA
GB20130020729–––

Members36

Family members, oldest first
DocumentOfficeKind
GB201320729D0United KingdomD0
CA2928009A1CanadaA1
WO2015075483A1World Intellectual Property Organization (WIPO)A1
AU2014351571A1AustraliaA1
IL245062A0IsraelA0
IL245062D0IsraelD0
KR20160079792ARepublic of KoreaA
CN105793260AChinaA
EA201690531A1Eurasian Patent Organization (EAPO)A1
EP3074396A1European Patent Office (EPO)A1
JP2016538345AJapanA
US2016355510A1United States of AmericaA1
MX2016006119AMexicoA
SA516371189ASaudi ArabiaA
US9725447B2United States of AmericaB2
US2017298066A1United States of AmericaA1
CN105793260BChinaB
SA516371189B1Saudi ArabiaB1
SA5981B1Saudi ArabiaB1
JP6389529B2JapanB2
US10167282B2United States of AmericaB2
AU2014351571B2AustraliaB2
EP3074396B1European Patent Office (EPO)B1
DK3074396T3DenmarkT3
PT3074396TThis recordPortugalT
IL245062AIsraelA
IL245062BIsraelB
PL3074396T3PolandT3
EA034216B1Eurasian Patent Organization (EAPO)B1
HUE045596T2HungaryT2
ES2740325T3SpainT3
MX372942BMexicoB
BR112016011078A8BrazilA8
KR102327096B1Republic of KoreaB1
CA2928009CCanadaC
BR112016011078B1BrazilB1